NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/15/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization90.13 mln
Float5.19 mln
Earnings Date06/15/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.72
Highly reliable
Relative Strength
92
/ 100
Top performer
Debt / Equity
1.14
Elevated leverage
ROE
-53.79
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Champions Oncology is a US-based research company that helps pharmaceutical and biotechnology firms develop cancer drugs by implanting human tumors into specially bred mice, allowing scientists to study how those tumors respond to treatment. The company also offers Lumin Bioinformatics, a software tool that pulls together data from research and clinical studies to support drug development decisions. Founded in 1985 and based in Hackensack, New Jersey, Champions Oncology reaches its clients through online channels and a dedicated sales team.
